# Clinical Studies

> **NIH NIH U19** · HARVARD MEDICAL SCHOOL · 2021 · $633,267

## Abstract

PROJECT SUMMARY: CORE B 
The proposed Center for Excellence in Translational Research combines four projects focused on developing a 
rapid molecular diagnostic to detect altered drug responses to Mycobacteria tuberculosis (Mtb). Core B, our 
proposed clinical research core, will support projects involving human subjects. We will build on systems and 
expertise that we have developed in previous work to provide services that include developing protocols to 
ensure all aspects of human subjects research meet NIH requirements; that all procedures and materials are in 
place for data management, quality control, storage and analysis; that data collection protocols are being 
implemented; that staff are trained in the research and understand its goals; and that specimen collection and 
clinical procedures are standard across sites.

## Key facts

- **NIH application ID:** 10131752
- **Project number:** 5U19AI142793-03
- **Recipient organization:** HARVARD MEDICAL SCHOOL
- **Principal Investigator:** MEGAN B MURRAY
- **Activity code:** U19 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $633,267
- **Award type:** 5
- **Project period:** 2019-04-18 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10131752

## Citation

> US National Institutes of Health, RePORTER application 10131752, Clinical Studies (5U19AI142793-03). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10131752. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*